Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.

Fortner, RTSarink, DSchock, HJohnson, TTjonneland, AOlsen, AOvervad, KAffret, AHis, MBoutron-Ruault, MCBueno de Mesquita, HBetal2025-03-252025-03-2520172817383410.1186/s12916-017-0786-8https://rivm.openrepository.com/handle/10029/650469Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.ArticleBMC Med 2017; 15(1):262025-03-25